|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| G16B 25/10 | (2019.01) |
| (11) | Patento numeris | 3179393 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16191856.0 |
| Europos patento paraiškos padavimo data | 2013-01-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-06-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261593106 P | 2012-01-31 | US | |
| 201261672679 P | 2012-07-17 | US | |
| 201261713734 P | 2012-10-15 | US |
| (72) |
SHAK, Steve, US
LEE, Mark, US
NOVOTNY, William, US
MADDALA, Tara, US
CRAGER, Michael, US
CHERBAVAZ, Diana, US
PELHAM, Robert, US
MILLWARD, Carl L., US
KNEZEVIC, Dejan, US
|
| (73) |
Genomic Health, Inc.,
301 Penobscot Drive, Redwood City, CA 94063,
US
|
| (54) | GENE EXPRESSION PROFILE ALGORITHM AND TEST FOR DETERMINING PROGNOSIS OF PROSTATE CANCER |
| GENE EXPRESSION PROFILE ALGORITHM AND TEST FOR DETERMINING PROGNOSIS OF PROSTATE CANCER |